Healthcare distribution platform Entero Healthcare has acquired Aayu Chemist app and MedCords platform for an undisclosed sum, the company said on March 20, in an effort to accelerate digitalization of retail chemists who have been disrupted by quick commerce.
“This move accelerates the digitalization of retail chemists, equipping them with cutting-edge tools to enhance business efficiency, profitability, and customer engagement,” Prabhat Agrawal, MD & CEO of Entero Healthcare said.
MedCords is a ML and cloud-based ecosystem connecting stakeholders to access and share medical data.
Retail pharmacies in India are facing challenges from quick commerce players, which are reshaping consumer expectations with faster deliveries and digital-first experiences. Entero has a network of over 86,000 retail chemists and the company wants to deepen engagement in the $50 billion Indian pharmaceutical market using technology for integration.
Entero said the HealthEdge programme aligns with its vision to be a ‘growth catalyst for retail chemists’, and the digital enablement will ‘empower them to stay ahead of the curve’, ensuring resilience and growth.
"Quick commerce is disrupting traditional chemist shops by shifting consumer spending," Shreyans Mehta, co-founder of Aayu Chemist by Medcords said. "This partnership with Entero brings our technology and expertise to a broader network, ensuring lakhs of chemists benefit from future-ready solutions."
Enetero is promising benefits such as superfast medicine supplies and inventory management to retail chemists, along with optimized logistics for stock availability. Chemists also stand to benefit from expiry management and auto-refill systems along with exclusive access to new products and high-margin deals, and the digital transition will engage customer with loyalty programs, e-payments, and medicine reminders, Entero said.
Entero Healthcare’s Q3FY25 earnings were strong, with 37% YoY revenue growth, 322% PAT growth compared to last year. The company has a network of 104 warehouses, partnership with over 3,200 hospitals and last-mile delivery infrastructure across 492 districts.
Entero has a market capitalization of around Rs 5,000 crore, and the shares of the company were higher by 16% over last one year, and down 20% so far this year.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
